Seeking expertise on addiction medicine...

Joseph Dal Molin dalmolin at e-cology.ca
Thu Feb 18 18:18:27 EST 2016


Have a look at the US Meaningful Use 1 & 2 quality measure smoking 
criteria... having said that, the smoking measures were/are so 
convoluted they probably encouraged substance abuse among the poor souls 
that had to figure out how to implement them.

Joseph

On 16-02-18 06:04 PM, Marcus Baw wrote:
> Hi Heather,
>
> I have a couple of years' experience dealing with and prescribing for 
> substance misuse in a British prison environment. The main drugs in 
> question were opioids, cocaine, amphetamines, benzodiazepines, 
> alcohol, and commonly abused prescription drugs such as pregabalin and 
> gabapentin.
>
> I'm not sure if this stuff is helpful from a 'modelling' point of view 
> but I'm happy to help out if it's in any way useful.
>
> M
>
> On 18 February 2016 at 06:55, Rikard Lövström 
> <rikard.lovstrom at gmail.com <mailto:rikard.lovstrom at gmail.com>> wrote:
>
>     Hi Heather,
>
>     I did a Powerpoint presentation in 2011 looken at 30 key figures
>     from quality registers on tobacco use, compared it to the 10 put
>     forward by an expert group and finally concluded on the two (!) I
>     thought was sufficient.
>
>     I can try to find it. By the weekend.
>
>     Kind regards,
>     Rikard
>
>     Rikard Lövström
>
>     Den 18 feb 2016 07:50 skrev "Heather Leslie"
>     <heather.leslie at oceaninformatics.com
>     <mailto:heather.leslie at oceaninformatics.com>>:
>
>         Hi everyone,
>
>         The CKM Editorial teams in Norway and the international
>         openEHR CKM are seeking expertise for development of our
>         tobacco, drug and alcohol archetypes – all of which follow a
>         similar pattern around addition and its management.
>
>         The tobacco archetype in particular is causing some difficulty
>         in cracking the best pattern – the multitude of ways that this
>         data is represented in current systems is compounded by the
>         multitude of different forms of tobacco use (non-smoking and
>         smoking) and forms of tobacco used in smoking… There has been
>         a lot of discussion and various iterations over the past few
>         years – it is now time to try to pin it down and publish.
>
>         We think that consultation with an expert or two in this area
>         will help us establish the best approach for a robust
>         candidate archetype, which will then go out to the community
>         for further review and collaboration.
>
>         If you’d like to volunteer your services, please let me know.
>
>         If you can refer me to someone else who could assist, please
>         do so.
>
>         Many thanks in anticipation,
>
>         Heather
>
>         *Dr Heather Leslie *MBBS FRACGP FACHI
>         *Informatics Lead*, Ocean Informatics
>         <http://www.oceaninformatics.com/>
>
>         *Clinical Programme Lead, *openEHR Foundation
>         <http://www.openehr.org/>
>         p: +61 418 966 670 <tel:%2B61%20418%20966%20670>   skype:
>         heatherleslie twitter: @omowizard
>
>
>         _______________________________________________
>         openEHR-clinical mailing list
>         openEHR-clinical at lists.openehr.org
>         <mailto:openEHR-clinical at lists.openehr.org>
>         http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
>
>
>     _______________________________________________
>     openEHR-clinical mailing list
>     openEHR-clinical at lists.openehr.org
>     <mailto:openEHR-clinical at lists.openehr.org>
>     http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
>
>
>
>
> _______________________________________________
> openEHR-clinical mailing list
> openEHR-clinical at lists.openehr.org
> http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org





More information about the openEHR-clinical mailing list